1. Home
  2. ADVM vs ACR Comparison

ADVM vs ACR Comparison

Compare ADVM & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • ACR
  • Stock Information
  • Founded
  • ADVM 2006
  • ACR 2005
  • Country
  • ADVM United States
  • ACR United States
  • Employees
  • ADVM N/A
  • ACR N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • ACR Real Estate Investment Trusts
  • Sector
  • ADVM Health Care
  • ACR Real Estate
  • Exchange
  • ADVM Nasdaq
  • ACR Nasdaq
  • Market Cap
  • ADVM 119.6M
  • ACR 136.9M
  • IPO Year
  • ADVM 2014
  • ACR N/A
  • Fundamental
  • Price
  • ADVM $4.74
  • ACR $15.80
  • Analyst Decision
  • ADVM Strong Buy
  • ACR Buy
  • Analyst Count
  • ADVM 6
  • ACR 2
  • Target Price
  • ADVM $27.83
  • ACR $17.50
  • AVG Volume (30 Days)
  • ADVM 226.5K
  • ACR 13.7K
  • Earning Date
  • ADVM 11-04-2024
  • ACR 10-30-2024
  • Dividend Yield
  • ADVM N/A
  • ACR N/A
  • EPS Growth
  • ADVM N/A
  • ACR N/A
  • EPS
  • ADVM N/A
  • ACR 0.83
  • Revenue
  • ADVM $1,000,000.00
  • ACR $77,437,000.00
  • Revenue This Year
  • ADVM N/A
  • ACR N/A
  • Revenue Next Year
  • ADVM $1,342.84
  • ACR N/A
  • P/E Ratio
  • ADVM N/A
  • ACR $18.99
  • Revenue Growth
  • ADVM N/A
  • ACR 8.77
  • 52 Week Low
  • ADVM $4.59
  • ACR $9.41
  • 52 Week High
  • ADVM $29.70
  • ACR $17.77
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 26.02
  • ACR 40.02
  • Support Level
  • ADVM $4.59
  • ACR $15.35
  • Resistance Level
  • ADVM $4.89
  • ACR $16.05
  • Average True Range (ATR)
  • ADVM 0.31
  • ACR 0.44
  • MACD
  • ADVM -0.06
  • ACR -0.25
  • Stochastic Oscillator
  • ADVM 9.80
  • ACR 31.27

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: